Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetic Kidney Disease”

329 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 329 results

Not applicableStudy completedNCT00253786
What this trial is testing

Study for the Effectiveness of Intensive Therapy Aiming at a Remission of Diabetic Nephropathy

Who this might be right for
Type 2 Diabetes MellitusDiabetic Nephropathy
Okayama University 312
Not applicableLooking for participantsNCT06586203
What this trial is testing

Clinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Cardiovascular DiseasesDiabetic Nephropathy Type 2
Optithera 2,714
Testing effectiveness (Phase 2)Study completedNCT00097955
What this trial is testing

Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria

Who this might be right for
Diabetic Nephropathy
Novartis Pharmaceuticals 496
Post-approval studies (Phase 4)Study completedNCT07247656
What this trial is testing

The Efficacy and Safety of Empagliflozin - Linagliptin and Empagliflozin- Metformin Therapy in Reduction of Body Weight in Type 2 Diabetic Patients .

Who this might be right for
Diabete Mellitus
Bahria University 200
Large-scale testing (Phase 3)UnknownNCT04589351
What this trial is testing

Kidney Fat in Type 2 Diabetes and the Effects of Ezetimibe

Who this might be right for
Diabetes Mellitus, Type 2Diabetic Kidney Disease
Steno Diabetes Center Copenhagen 60
Testing effectiveness (Phase 2)Study completedNCT01874431
What this trial is testing

Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathies
Bayer 823
Not applicableNot Yet RecruitingNCT06668753
What this trial is testing

Effect of SGLT2 Inhibitors on NAFLD in Type 2 Diabetic Patients with Diabetic Nephropathy

Who this might be right for
Effect of SGLT2 Inhibitors NAFLD in Type 2 Diabetic Patients with Diabetic Nephropathy
Assiut University 114
Not applicableActive Not RecruitingNCT07348718
What this trial is testing

Rubix LS Diabetic Kidney Disease (DKD) Registry Study

Who this might be right for
Diabetic Kidney Disease (DKD)
Rubix LS 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT05759468
What this trial is testing

NAD Augmentation in Diabetes Kidney Disease

Who this might be right for
Type2diabetesDiabetic Kidney Disease
Brigham and Women's Hospital 156
Post-approval studies (Phase 4)Study completedNCT01664676
What this trial is testing

Effects of Liraglutide on Kidney Function in Type 2 Diabetic Patients

Who this might be right for
Type 2 Diabetes Mellitus
University of Aarhus 11
Early research (Phase 1)Study completedNCT00754143
What this trial is testing

Phase 1 Study of FG-3019 in Subjects With Type 1 or Type 2 Diabetes Mellitus and Diabetic Nephropathy

Who this might be right for
Diabetes MellitusDiabetic Nephropathy
Kyntra Bio 38
Testing effectiveness (Phase 2)Study completedNCT04595370
What this trial is testing

Efficacy, Safety and Tolerability of AZD9977 and Dapagliflozin in Participants With Heart Failure and Chronic Kidney Disease

Who this might be right for
Heart FailureChronic Kidney Disease
AstraZeneca 153
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06072326
What this trial is testing

DApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation

Who this might be right for
Type 1 Diabetes Mellitus With Diabetic Nephropathy
University Medical Center Groningen 36
Not applicableStudy completedNCT01390415
What this trial is testing

Evaluate Whether Losartan Protects the Kidney in Hypertensive Diabetic Participants With Microalbuminuria (MK0954-365 AM1)

Who this might be right for
Hypertension
Organon and Co 136
Post-approval studies (Phase 4)Ended earlyNCT03152084
What this trial is testing

The Study Will Evaluate Average 24-hr Sodium Excretion During Dapagliflozin Treatment in Patients With Type 2 Diabetes Mellitus With Preserved or Impaired Renal Function or Non-diabetics With Impaired Renal Function.

Who this might be right for
Diabetes Mellitus, Type 2Kidney Function Tests
AstraZeneca 24
Large-scale testing (Phase 3)Study completedNCT07591077
What this trial is testing

SGLT2 Adjunct in T1D

Who this might be right for
Type 1 DiabetesNephropathy, Diabetic
Ain Shams University 86
Early research (Phase 1)Ended earlyNCT01488877
What this trial is testing

Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy

Who this might be right for
Type 2 Diabetic Nephropathy
Pfizer 6
Testing effectiveness (Phase 2)Study completedNCT00734253
What this trial is testing

Safety and Efficacy Study of Pyridorin in Patients With Nephropathy Due to Type 2 Diabetes

Who this might be right for
Diabetic Nephropathy
NephroGenex, Inc. 317
Testing effectiveness (Phase 2)Study completedNCT05514548
What this trial is testing

Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease
Inversago Pharma Inc. 265
Large-scale testing (Phase 3)Study completedNCT00274118
What this trial is testing

DETAIL Study: Diabetes Exposed to Telmisartan and Enalapril

Who this might be right for
HypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim 250
Next Page